These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38686026)
1. Comparison of carbapenem MIC for NDM-producing Enterobacterales by different AST methods. Lee ALH; Leung ECM; Chow VCY JAC Antimicrob Resist; 2024 Apr; 6(2):dlae028. PubMed ID: 38686026 [TBL] [Abstract][Full Text] [Related]
2. Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible Zhang J; Jia P; Zhu Y; Zhang G; Xu Y; Yang Q Front Med (Lausanne); 2021; 8():643194. PubMed ID: 33937287 [No Abstract] [Full Text] [Related]
3. Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest. Nana T; Perovic O; Chibabhai V Clin Microbiol Infect; 2022 Dec; 28(12):1650.e1-1650.e5. PubMed ID: 35811020 [TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of Papadomanolaki A; Siopi M; Karakosta P; Vourli S; Pournaras S Antibiotics (Basel); 2022 Jun; 11(7):. PubMed ID: 35884118 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of Cortazzo V; Posteraro B; Menchinelli G; Liotti FM; D'Inzeo T; Fiori B; Luzzaro F; Sanguinetti M; Spanu T Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009892 [TBL] [Abstract][Full Text] [Related]
6. Multicenter Clinical Evaluation of Vitek 2 Meropenem-Vaborbactam for Susceptibility Testing of Dwivedi HP; Franklin S; Chandrasekaran S; Garner O; Traczewski MM; Beasley D; Procop GW; Tuohy M; Wilson D; Bala Y; Pincus DH J Clin Microbiol; 2022 Jan; 60(1):e0161021. PubMed ID: 34705536 [TBL] [Abstract][Full Text] [Related]
7. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685 [TBL] [Abstract][Full Text] [Related]
8. Use of Fosfomycin Etest To Determine Karlowsky JA; Baxter MR; Golden AR; Adam HJ; Walkty A; Lagacé-Wiens PRS; Zhanel GG J Clin Microbiol; 2021 Nov; 59(12):e0163521. PubMed ID: 34495708 [TBL] [Abstract][Full Text] [Related]
9. Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli. Antonelli A; Coppi M; Camarlinghi G; Parisio EM; Nardone M; Riccobono E; Giani T; Mattei R; Rossolini GM Clin Microbiol Infect; 2019 Nov; 25(11):1432.e1-1432.e4. PubMed ID: 31425743 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of different methods for Rout B; Dash SK; Sahu KK; Behera B; Praharaj I; Otta S Access Microbiol; 2023; 5(10):. PubMed ID: 37970087 [TBL] [Abstract][Full Text] [Related]
11. Multicenter Clinical Evaluation of Etest Meropenem-Vaborbactam (bioMérieux) for Susceptibility Testing of Jean S; Garrett S; Anglade C; Bridon L; Davies L; Garner OB; Richards J; Wallace M; Wootton M; Burnham CA J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31619532 [TBL] [Abstract][Full Text] [Related]
12. Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and Chew KL; La MV; Lin RTP; Teo JWP J Clin Microbiol; 2017 Sep; 55(9):2609-2616. PubMed ID: 28592552 [TBL] [Abstract][Full Text] [Related]
13. Performance Evaluation of the Gradient Diffusion Strip Method and Disk Diffusion Method for Ceftazidime-Avibactam Against Zhang J; Li G; Zhang G; Kang W; Duan S; Wang T; Li J; Huangfu Z; Yang Q; Xu Y; Jia W; Sun H Front Microbiol; 2021; 12():710526. PubMed ID: 34603236 [No Abstract] [Full Text] [Related]
14. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems]. Kuzucu C; Yetkin F; Görgeç S; Ersoy Y Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156 [TBL] [Abstract][Full Text] [Related]
15. Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing. Tato M; Morosini M; García L; Albertí S; Coque MT; Cantón R J Clin Microbiol; 2010 Nov; 48(11):4089-93. PubMed ID: 20844213 [TBL] [Abstract][Full Text] [Related]